Health Care · Health Care Supplies · US stock · price as of 16 Oct 2026
Key indicators
Price
$57.94
52-week range
$51.01 – $89.83
Market cap
$11.2B
P/E (trailing)
19.9×
EV / EBITDA
15.3×
Free-cash-flow yield
6.1%
Dividend yield
–
Revenue (last 12 months)
$4.2B
Revenue growth (3y a year)
7.3%
Operating margin
12.8%
Return on invested capital
4.3%
Net debt / EBITDA
3.2×
Fair value
Blended fair value$60.11 range $58 – $63
Versus priceFair+4% to fair value
Peer multiples
$76.61
Fundamentals-adjusted multiple
$71.29
10-year DCF (market-scaled)
$32.43
Earnings power value (floor, not blended)
$21.68
Model uncertainty
Medium
X-Ray Score
46/ 100 · High confidence · ahead of 33% of sector peers
Valuation57
Growth46
Profitability37
Financial health42
Dividends–
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Cooper Companies develops and manufactures medical devices through two businesses. CooperVision makes soft contact lenses, which it supplies to eye care professionals and retailers around the world, while CooperSurgical focuses on products for women's health, fertility and newborn care used by hospitals, clinics and fertility specialists.
Revenue comes from the recurring supply of contact lenses and from surgical, diagnostic and fertility products. In the last twelve months it was $4.2 billion, growing at 7.3% a year across the last three years. The operating margin is 12.8%, and the business earns a profit of 4% on the capital invested in it. It has net debt of 3.2 times EBITDA. The company does not pay a dividend.
StocksXray gives Cooper Companies, Inc. an X-Ray Score of 46 out of 100 (high confidence), ahead of 33% of the S&P 500 stocks in its sector. Its strongest lens is valuation (57) and its weakest is profitability (37).
Our fair value blend is $60.11 (range $57.67 to $63.43). At $57.94 the stock trades 4% below that blend, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Cooper Companies, Inc. (COO)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$104.20
$68.34
$77.94
$104.68
$69.91
$57.94
Market cap
$5.2B
$13.6B
$15.5B
$21.0B
$14.0B
$11.2B
P/E
1.8×
35.2×
52.7×
53.4×
37.4×
19.9×
EV / revenue
2.3×
5.0×
5.0×
6.0×
4.0×
3.4×
EV / EBITDA
8.2×
19.4×
20.0×
21.7×
15.5×
15.3×
Price / free cash flow
9.9×
30.2×
72.2×
72.8×
32.2×
16.5×
Free-cash-flow yield
10.1%
3.3%
1.4%
1.4%
3.1%
6.1%
Price / book
0.7×
1.9×
2.1×
2.6×
1.7×
1.3×
Dividend yield
0.03%
0.01%
0.01%
–
–
–
Fundamentals checklist ● 3 Good · ● 8 Average · ● 5 Bad · each check graded against the sector
Cash quality
Earnings backed by cash−3.7%Average
Free-cash-flow yield6.1%Good
Risk models
Altman Z score4.6×Good
Piotroski F-Score6 of 9Average
Growth
EPS growth (3y)−1.2%Bad
Free-cash-flow growth (3y)−1.3%Average
Revenue growth (3y)7.3%Average
Growth consistency100%Good
Balance sheet
Current ratio1.2×Bad
Net debt / EBITDA3.2×Bad
Interest cover6.1×Average
Valuation
Fair value vs price1.0×Average
EBIT / EV yield3.8%Average
Profitability
Return on invested capital4.3%Bad
Operating margin12.8%Average
Gross profitability22.0%Bad
XStocksXray
Cooper Companies, Inc. (COO)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
2,923
3,308
3,593
3,895
4,092
4,237
Gross profit
1,956
2,140
2,358
2,596
2,682
2,793
Operating income
506
508
533
706
683
544
Net income
2,945
386
294
392
375
570
Diluted EPS ($)
59.16
1.94
1.48
1.96
1.87
2.91
Free cash flow
524
450
215
288
434
678
Gross margin
66.9%
64.7%
65.6%
66.6%
65.5%
65.9%
Operating margin
17.3%
15.3%
14.8%
18.1%
16.7%
12.8%
Net margin
100.8%
11.7%
8.2%
10.1%
9.2%
13.5%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
9,606
11,492
11,659
12,315
12,395
12,673
Cash
96
138
121
108
111
155
Total debt
1,562
3,155
2,610
2,614
2,551
3,170
Equity
6,942
7,175
7,551
8,083
8,239
8,328
Dividend per share ($)
0.03
0.01
0.01
–
–
–
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.